Ad
related to: is drospirenone a diuretic factor- Request a Rep & Samples
Visit HCP Site to Request a
Mayne Pharma Representative.
- Dosing & Prescribing
Learn More About Starting
Your Patients on NEXTSTELLIS®.
- Why NEXTSTELLIS®
Learn More About NEXTSTELLIS®
& Its Tolerability. Visit HCP Site.
- NEXTSTELLIS® Safety
Visit HCP Site for the Long-Term
Safety Profile of NEXTSTELLIS®.
- Request a Rep & Samples
Search results
Results from the WOW.Com Content Network
Drospirenone is a progestin and antiandrogen medication which is used in birth control pills to prevent pregnancy and in menopausal hormone therapy, among other uses. [1] [10] It is available both alone under the brand name Slynd and in combination with an estrogen under the brand name Yasmin among others.
Each box, as supplied by the manufacturer, contains three blister packs of 28 tablets packaged in individual boxes. Each blister pack of 28 tablets contains 24 pink active pills containing drospirenone 3 mg, ethinylestradiol 20 mcg, and levomefolate calcium 0.451 mg and four light orange inactive pills containing levomefolate calcium 0.451 mg. [7] [9]
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.
Estradiol/drospirenone (E2/DRSP), sold under the brand name Angeliq, is a combination of estradiol (E2), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used in menopausal hormone therapy, specifically the treatment of menopausal syndrome and osteoporosis, in postmenopausal women.
Pictured recipe: Spinach Salad with Roasted Sweet Potatoes, White Beans & Basil Health Benefits of White Beans Potassium. If there is one mineral that is revered for its ability to aid in blood ...
Drospirenone/estetrol, sold under the brand name Nextstellis, among others, is a fixed-dose combination medication containing drospirenone, a progestin, and estetrol, an estrogen, which is used as a combined birth control pill for the prevention of pregnancy in women. [2] [6] It is taken by mouth. [2] [6]
Missing data is also a factor that limits the findings. Researchers noted that one study did not have data on fruit and vegetable intake, so this data had to be imputed. However, the analysis that ...
The US Food and Drug Administration (FDA) initiated studies evaluating the health of more than 800,000 women taking combined oral contraceptive pills and found that the risk of VTE was 93% higher for women who had been taking drospirenone combined oral contraceptive pills for 3 months or less and 290% higher for women taking drospirenone ...
Ad
related to: is drospirenone a diuretic factor